Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

NCT05358639 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

High Grade Serous Carcinoma
Triple Negative Breast Cancer
Ovarian Cancer

Interventions

DRUG: Olaparib tablet
DRUG: Navitoclax

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]
[object Object]